Since 2013, Canadian Clinical Cannabinoids Inc. (CCC) , a wholly owned subsidiary of Truverra, has invested in state of the art equipment and world class GMP quality systems to meet the growing demands of the market for extraction and purification services that meet international quality standards.
CCC recognizes that significant achievements come to life through partnership and collaboration, and we are committed to working closely with licensed producers, researchers, the food and beverage industry, and pharmaceutical companies to meet the growing demand for high quality oils, distillates and purified concentrates. Our strong customer service orientation and unwavering commitment to upholding the highest quality standards define our relationships with partners and clients.
We are developing a new, innovative approach to health science that will reshape the future of medical treatments and how humanity heals. Our passion is rooted in a culture of innovation, collaboration, integrity, and diversity that seeks to help those in need. And for those in need, our desire is to provide better health outcomes for patients and the healthcare practitioners that care for them.